The mystery of Moderna’s magic algorithm
Key Points:
- Moderna and Merck have developed a personalized cancer vaccine, intismeran autogene, which showed success in a late-stage trial, generating significant excitement.
- If approved by regulators, the vaccine would represent a major breakthrough in immunology and cancer biology.
- The vaccine is notable for being the first approved medicine whose genetic instructions are designed by a computer algorithm, highlighting the role of AI in medical innovation.